Xu Li

机构：Collaborative Innovation Center of Chemical Science and Engineering Tianjin · ORCID：0000-0001-8051-9141

发表论文 165 篇 · 总被引 2690 次 · h-index 30

代表论文

• Magnesium Nanocomposite Hydrogel Reverses the Pathologies to Enhance Mandible Regeneration (2024 · Advanced Materials · 被引 46)
• Excess glucocorticoids inhibit murine bone turnover via modulating the immunometabolism of the skeletal microenvironment (2024 · Journal of Clinical Investigation · 被引 39)
• Renal aging and mitochondrial quality control (2024 · Biogerontology · 被引 7)
• Potential of FGF21 in type 2 diabetes mellitus treatment based on untargeted metabolomics (2024 · Biochemical Pharmacology · 被引 6)
• Metabolic cell deaths in head and neck cancer: mechanisms, therapeutic potential, and challenges (2025 · Annals of Medicine · 被引 4)
• Orchestration of Pathological Osteoclast‐Chondrocyte Communication via Acid‐Responsive Nanotherapeutics for Articular Cartilage Regeneration (2025 · Advanced Functional Materials · 被引 4)